K+S Aktiengesellschaft

LSE:0Q2N Stock Report

Market Cap: €2.7b

K+S Valuation

Is 0Q2N undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0Q2N when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
€9.49
Fair Value
60.7% overvalued intrinsic discount
16
Number of Analysts

Below Fair Value: 0Q2N (€15.26) is trading above our estimate of fair value (€9.49)

Significantly Below Fair Value: 0Q2N is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0Q2N?

Key metric: As 0Q2N is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0Q2N. This is calculated by dividing 0Q2N's market cap by their current revenue.
What is 0Q2N's PS Ratio?
PS Ratio0.7x
Sales€3.65b
Market Cap€2.74b

Price to Sales Ratio vs Peers

How does 0Q2N's PS Ratio compare to its peers?

The above table shows the PS ratio for 0Q2N vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.7x
JMAT Johnson Matthey
0.2x-33.37%UK£2.3b
CRDA Croda International
2.7x5.30%UK£4.4b
VCT Victrex
2.5x5.14%UK£733.2m
ELM Elementis
1.3x3.20%UK£733.4m
0Q2N K+S
0.7x1.77%€2.7b

Price-To-Sales vs Peers: 0Q2N is good value based on its Price-To-Sales Ratio (0.7x) compared to the peer average (1.7x).

Price to Sales Ratio vs Industry

How does 0Q2N's PS Ratio compare vs other companies in the GB Chemicals Industry?

6 CompaniesPrice / SalesEstimated GrowthMarket Cap
JMAT Johnson Matthey
0.2x-33.37%US$2.97b
SYNT Synthomer
0.09x3.05%US$239.13m
CAR Carclo
0.2x9.55%US$37.73m
HEIQ HeiQ
0.2xn/aUS$9.61m
0Q2N 0.7xIndustry Avg. 1.0xNo. of Companies6PS012345+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 0Q2N is good value based on its Price-To-Sales Ratio (0.7x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is 0Q2N's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0Q2N PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.7x
Fair PS Ratio0.5x

Price-To-Sales vs Fair Ratio: 0Q2N is expensive based on its Price-To-Sales Ratio (0.7x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0Q2N forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€15.26
€14.01
-8.17%
19.98%€18.00€9.50n/a16
May ’26€15.33
€13.86
-9.61%
19.88%€18.00€9.50n/a16
Apr ’26€12.69
€12.52
-1.37%
23.52%€17.50€8.00n/a16
Mar ’26€13.21
€11.95
-9.53%
22.32%€17.50€8.00n/a16
Feb ’26€13.35
€11.90
-10.86%
22.65%€17.50€8.00n/a16
Jan ’26€10.39
€11.49
+10.61%
25.04%€17.50€7.50n/a16
Dec ’25€11.14
€11.51
+3.32%
24.92%€17.50€7.50n/a16
Nov ’25€11.19
€12.40
+10.78%
25.46%€18.00€7.50n/a17
Oct ’25€11.50
€13.14
+14.29%
25.08%€19.00€7.50n/a17
Sep ’25€10.74
€13.42
+25.03%
25.26%€19.00€7.50n/a17
Aug ’25€11.88
€14.61
+23.02%
20.77%€20.00€10.00n/a17
Jul ’25€12.51
€15.24
+21.83%
18.19%€20.00€10.00n/a17
Jun ’25€13.53
€15.31
+13.08%
17.54%€20.00€10.00n/a17
May ’25€14.11
€15.46
+9.59%
17.15%€20.00€10.00€15.3317
Apr ’25€14.58
€15.55
+6.62%
16.92%€20.00€10.00€12.6916
Mar ’25€13.08
€16.69
+27.62%
20.62%€23.00€11.00€13.2116
Feb ’25€12.77
€16.69
+30.69%
20.62%€23.00€11.00€13.3516
Jan ’25€14.24
€18.01
+26.47%
17.07%€23.00€13.00€10.3916
Dec ’24€13.50
€18.21
+34.86%
15.74%€23.00€13.00€11.1416
Nov ’24€15.64
€19.45
+24.38%
15.69%€25.00€16.00€11.1916
Oct ’24€17.35
€19.64
+13.17%
16.25%€25.00€15.00€11.5016
Sep ’24€17.51
€19.64
+12.17%
16.25%€25.00€15.00€10.7416
Aug ’24€17.26
€19.18
+11.14%
15.92%€25.00€15.00€11.8816
Jul ’24€15.95
€20.07
+25.81%
15.81%€26.00€16.00€12.5116
Jun ’24€15.03
€20.76
+38.15%
17.57%€27.00€16.70€13.5316
May ’24€18.09
€23.58
+30.30%
17.25%€30.00€17.00€14.1116
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
€13.99
Fair Value
9.0% overvalued intrinsic discount
16
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/13 14:13
End of Day Share Price 2025/05/12 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

K+S Aktiengesellschaft is covered by 56 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephen WilderAlliance Global Partners
Martin SchneeAlphaValue
Andrew BensonAuerbach Grayson